• Spectral AI showcased DeepView System at 2026 American Burn Association Annual Meeting held April 14-17 in Orlando.
• Clinicians presented DeepView data to more than 2,200 attendees, supporting Spectral AI’s push toward commercialization following its June 2025 FDA De Novo 510(k) marketing clearance submission.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604220830PRIMZONEFULLFEED9694583) on April 22, 2026, and is solely responsible for the information contained therein.